Evista is a prescription medication containing raloxifene hydrochloride, a selective estrogen receptor modulator (SERM). It is prescribed for the prevention and treatment of osteoporosis in postmenopausal women and, in some patients, to reduce the risk of invasive breast cancer based on individual risk factors.

Raloxifene acts selectively on estrogen receptors in different tissues, helping maintain bone density while having different effects in breast and uterine tissue. Treatment should be initiated and monitored by a qualified healthcare professional.

Key Information

• Contains raloxifene hydrochloride.
• Selective estrogen receptor modulator (SERM).
• Used in postmenopausal women for approved indications.
• Prescription-only medication.
• Should be taken only under medical supervision.

Active Ingredient

Raloxifene Hydrochloride

Strength

Varies by manufacturer.

Pack Size

Available according to manufacturer packaging.

Indications

• Prevention and treatment of osteoporosis in postmenopausal women.
• Reduction of invasive breast cancer risk in certain eligible patients.
• Use only as prescribed by a qualified healthcare professional.

Directions for Use

Take the medication exactly as directed by your healthcare provider. Continue treatment for the prescribed duration and attend regular follow-up appointments as recommended.

Storage

Store at room temperature in the original packaging, protected from moisture, excessive heat, and direct sunlight. Keep out of the reach of children.